ORNL's Scott Curran, group leader for Fuel Science and Engine Technologies Research, has been named a fellow of SAE International and ASME.
ORNL researchers have developed a novel way to encapsulate salt hydrate phase-change materials within polymer fibers through a coaxial pulling process. The discovery could lead to the widespread use of the low-carbon materials as a source of insulation for a building’s envelope.
Oak Ridge National Laboratory scientists identified a gene “hotspot” in the poplar tree that triggers dramatically increased root growth. The discovery supports development of better bioenergy crops and other plants that can thrive in difficult conditions while storing more carbon belowground.
Oak Ridge National Laboratory scientists studied hot springs on different continents and found similarities in how some microbes adapted despite their geographic diversity.
Michelle Kidder, a senior R&D staff scientist at ORNL, has received the American Chemical Society’s Energy and Fuels Division’s Mid-Career Award for sustained and distinguished contributions to the field of energy and fuel chemistry.
ORNL researchers have developed a training camp to help manufacturing industries reduce energy-related carbon dioxide emissions and improve cost savings.
In the search for ways to fight methylmercury in global waterways, scientists at Oak Ridge National Laboratory discovered that some forms of phytoplankton are good at degrading the potent neurotoxin.
Nonfood, plant-based biofuels have potential as a green alternative to fossil fuels, but the enzymes required for production are too inefficient and costly to produce. However, new research is shining a light on enzymes from fungi that could make biofuels economically viable.
Oak Ridge National Laboratory scientists led the development of a supply chain model revealing the optimal places to site farms, biorefineries, pipelines and other infrastructure for sustainable aviation fuel production.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.